Lotus Pharmaceutical (Taiwan) Price Prediction
| 1795 Stock | TWD 279.50 3.50 1.24% |
Oversold Vs Overbought
62
Oversold | Overbought |
Using Lotus Pharmaceutical hype-based prediction, you can estimate the value of Lotus Pharmaceutical Co from the perspective of Lotus Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Lotus Pharmaceutical to buy its stock at a price that has no basis in reality. In that case, they are not buying Lotus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Lotus Pharmaceutical after-hype prediction price | TWD 279.5 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Lotus |
Lotus Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Lotus Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Lotus Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Lotus Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Lotus Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Lotus Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Lotus Pharmaceutical's historical news coverage. Lotus Pharmaceutical's after-hype downside and upside margins for the prediction period are 277.46 and 281.54, respectively. We have considered Lotus Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Lotus Pharmaceutical is very steady at this time. Analysis and calculation of next after-hype price of Lotus Pharmaceutical is based on 3 months time horizon.
Lotus Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Lotus Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Lotus Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Lotus Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.02 | 2.04 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
279.50 | 279.50 | 0.00 |
|
Lotus Pharmaceutical Hype Timeline
Lotus Pharmaceutical is presently traded for 279.50on Taiwan Stock Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Lotus is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at -0.02%. %. The volatility of related hype on Lotus Pharmaceutical is about 0.0%, with the expected price after the next announcement by competition of 279.50. About 62.0% of the company shares are owned by insiders or employees . The book value of Lotus Pharmaceutical was presently reported as 51.3. The company recorded earning per share (EPS) of 11.86. Lotus Pharmaceutical last dividend was issued on the 4th of August 2022. The entity had 1060:1000 split on the 8th of September 2010. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Lotus Pharmaceutical Basic Forecasting Models to cross-verify your projections.Lotus Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Lotus Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Lotus Pharmaceutical's future price movements. Getting to know how Lotus Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Lotus Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 4123 | Center Laboratories | 0.00 | 0 per month | 1.29 | 0 | 3.66 | (2.12) | 7.66 | |
| 6620 | Handa Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.32) | 3.67 | (3.17) | 14.23 | |
| 6539 | DV Biomed Co | 0.00 | 0 per month | 0.00 | (0.17) | 1.43 | (1.60) | 8.02 | |
| 6785 | Alar Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.20) | 3.27 | (4.19) | 17.17 | |
| 3054 | LIWANLI Innovation Co | 0.00 | 0 per month | 1.23 | (0) | 3.26 | (1.92) | 14.48 |
Lotus Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Lotus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Lotus using various technical indicators. When you analyze Lotus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Lotus Pharmaceutical Predictive Indicators
The successful prediction of Lotus Pharmaceutical stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Lotus Pharmaceutical Co, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Lotus Pharmaceutical based on analysis of Lotus Pharmaceutical hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Lotus Pharmaceutical's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Lotus Pharmaceutical's related companies.
Story Coverage note for Lotus Pharmaceutical
The number of cover stories for Lotus Pharmaceutical depends on current market conditions and Lotus Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Lotus Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Lotus Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Lotus Pharmaceutical Short Properties
Lotus Pharmaceutical's future price predictability will typically decrease when Lotus Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Lotus Pharmaceutical Co often depends not only on the future outlook of the potential Lotus Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Lotus Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 262.2 M |
Additional Tools for Lotus Stock Analysis
When running Lotus Pharmaceutical's price analysis, check to measure Lotus Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lotus Pharmaceutical is operating at the current time. Most of Lotus Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Lotus Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lotus Pharmaceutical's price. Additionally, you may evaluate how the addition of Lotus Pharmaceutical to your portfolios can decrease your overall portfolio volatility.